| Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression N Bobrovitz, H Ware, X Ma, Z Li, R Hosseini, C Cao, A Selemon, ... The Lancet Infectious Diseases 23 (5), 556-567, 2023 | 353 | 2023 |
| Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysis N Bobrovitz, RK Arora, C Cao, E Boucher, M Liu, C Donnici, ... PloS one 16 (6), e0252617, 2021 | 246 | 2021 |
| Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies I Bergeri, MG Whelan, H Ware, L Subissi, A Nardone, HC Lewis, Z Li, ... PLoS medicine 19 (11), e1004107, 2022 | 124 | 2022 |
| SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021 HC Lewis, H Ware, M Whelan, L Subissi, Z Li, X Ma, A Nardone, ... BMJ Global Health 7 (8), e008793, 2022 | 115 | 2022 |
| Global epidemiology of SARS-CoV-2 infection: a systematic review and meta-analysis of standardized population-based seroprevalence studies, Jan 2020-Dec 2021 I Bergeri, M Whelan, H Ware, L Subissi, A Nardone, HC Lewis, Z Li, X Ma, ... MedRxiv 2021, 2022 | 48 | 2022 |
| Adapting serosurveys for the SARS-CoV-2 vaccine era N Duarte, M Yanes-Lane, RK Arora, N Bobrovitz, M Liu, MG Bego, T Yan, ... Open forum infectious diseases 9 (2), ofab632, 2022 | 41 | 2022 |
| Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response R Arora, C Cao, M Kumar, S Sinha, A Chanda, R McNeil, D Samuel, ... Nature Communications 14 (1), 5029, 2023 | 24 | 2023 |
| Protective effectiveness of prior SARS-CoV-2 infection and hybrid immunity against Omicron infection and severe disease: a systematic review and meta-regression N Bobrovitz, H Ware, X Ma, Z Li, R Hosseini, C Cao, A Selemon, ... MedRxiv, 2022.10. 02.22280610, 2022 | 22 | 2022 |
| Unity Studies Collaborator Group. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies I Bergeri, MG Whelan, H Ware, L Subissi, A Nardone, HC Lewis, Z Li, ... PLoS Med 19 (11), e1004107, 2022 | 16 | 2022 |
| Global SARS-CoV-2 seroprevalence: a systematic review and meta-analysis of standardized population-based studies from Jan 2020-May 2022 I Bergeri, M Whelan, H Ware, L Subissi, A Nardone, HC Lewis, Z Li, X Ma, ... medRxiv, 2021.12. 14.21267791, 2021 | 15 | 2021 |
| Timeliness of reporting of SARS-CoV-2 seroprevalence results and their utility for infectious disease surveillance C Donnici, N Ilincic, C Cao, C Zhang, G Deveaux, D Clifton, D Buckeridge, ... Epidemics 41, 100645, 2022 | 5 | 2022 |
| Occupation and SARS-CoV-2 seroprevalence studies: a systematic review E Boucher, C Cao, S D’Mello, N Duarte, C Donnici, N Duarte, G Bennett, ... BMJ open 13 (2), e063771, 2023 | 4 | 2023 |
| SeroTracker-RoB: an approach to automating reproducible risk of bias assessment of seroprevalence studies N Bobrovitz, K Noël, Z Li, C Cao, G Deveaux, A Selemon, DA Clifton, ... medRxiv, 2021.11. 17.21266471, 2021 | 4 | 2021 |
| SeroTracker-ROB: reproducible decision rules for risk of bias assessment of seroprevalence studies N Bobrovitz, KC Noel, Z Li, C Cao, G Deveaux, A Selemon, MY Lane, ... Epidemiology, 2021 | 4 | 2021 |
| Serology assays used in SARS-CoV-2 seroprevalence surveys worldwide: a systematic review and meta-analysis of assay features, testing algorithms, and performance X Ma, Z Li, MG Whelan, D Kim, C Cao, M Yanes-Lane, T Yan, T Jaenisch, ... Vaccines 10 (12), 2000, 2022 | 3 | 2022 |
| SeroTracker‐RoB: A decision rule‐based algorithm for reproducible risk of bias assessment of seroprevalence studies N Bobrovitz, K Noël, Z Li, C Cao, G Deveaux, A Selemon, DA Clifton, ... Research Synthesis Methods 14 (3), 414-426, 2023 | 2 | 2023 |
| Prompting is all you need: LLMs for systematic review screening C Cao, J Sang, R Arora, R Kloosterman, M Cecere, J Gorla, R Saleh, ... medRxiv, 2024.06. 01.24308323, 2024 | | 2024 |
| Adherence of SARS-CoV-2 seroepidemiologic studies to the ROSES-S reporting guideline during the COVID-19 pandemic (preprint) B Cheng, E Loeschnik, A Selemon, R Hosseini, J Yuan, H Ware, X Ma, ... | | 2023 |
| Adherence of SARS-CoV-2 seroepidemiologic studies to the ROSES-S reporting guideline during the COVID-19 pandemic B Cheng, E Loeschnik, A Selemon, R Hosseini, J Yuan, H Ware, X Ma, ... medRxiv, 2023.06. 02.23290895, 2023 | | 2023 |
| Spatial transcriptomics unravels novel signaling patterns at the leading edge of oral squamous cell carcinoma. R Arora, C Cao, M Kumar, A Chanda, D Samuel, W Matthews, ... Journal of Clinical Oncology, 2022 | | 2022 |
Rahul K. AroraAdjunct Assistant Professor, University of Calgary在 ucalgary.ca 的电子邮件经过验证
